Compare Indopoly Swakarsa Industry Tbk (IPOL) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indopoly Swakarsa Industry Tbk vs Tempo Scan Pacific Tbk. — how do they compare? Indopoly Swakarsa Industry Tbk trades at Rp113 (market cap 728.1B, 425.2K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,790 (market cap 12.58T, 212.4K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 17.3× Indopoly Swakarsa Industry Tbk's market cap, and Indopoly Swakarsa Industry Tbk is more actively traded (425.2K versus 212.4K). Which is the better fit depends on your goals.
| IPOL | TSPC | |
|---|---|---|
Market Cap | 728.1B | 12.58T |
Volume | 425.2K | 212.4K |
Lot | 4.25K | 2.12K |
Turnover | 48.52M | 586.54M |
Average Price | 114.12 | 2,761.5 |
Value | 48.52M | 586.54M |
Indicative Equilibrium Price | 113 | 2,790 |
Indicative Equilibrium Volume | 1.1K | 3.9K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Indopoly Swakarsa Industry Tbk
PT Indopoly Swakarsa Industry (the company) was established on 24 Mar 1995 based on Notaries Deed No. 114 and the deed of establishment was approved by the the Ministry of Justice dated Dec 22, 1995. The Company’s articles of association has been amended several times, most recently by notarial deed No. 5 of Popie Savitri, S.H., dated Mar 1, 2010, concerning among others, the change in the Company’s name, and public offering.
Read more on IPOL →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
